Cell counting startup Ovizio Imaging Systems secures $9.1m in round including university investment consortium Qbic.
Ovizio Imaging Systems, a Belgium-based life sciences company, has raised $9.1m.
The round was led by New Science Ventures, with support from Nausicaa Ventures and a number of private investors. Qbic, a university venturing fund supported by a consortium of universities in Belgium, also joined the round.
Ovizio will use the cash to expand its research and development team and to bring its cell counting technology into the in-vitro diagnostics market.
Philip Mathuis, CEO and co-founder of Ovizio, said: “The financial support will allow us to continue developing a platform technology and global commercial organisation to address unmet needs in our markets and to improve the day to day operations of our clients. The funds will also allow us to apply our technology to the in vitro diagnostics market where it has the potential for early disease detection at a reduced cost.”